Next Generation Target Product Profiles
How Real-World Data delivers precise insights
White Paper
Feb 20, 2018

Combining real-world data (RWD) synergistically with primary market research (PMR) delivers more granular and robust insights to enable more effective development of next generation Target Product Profiles (TPPs) through overcoming the inherent methodological limitations of a traditional PMR-only approach.

The next generation TPP informed by such a rich and robust insight foundation is better equipped to support internal decision making and forecasts, while holding up to increased scrutiny by healthcare stakeholders and addressing demand for demonstrating differential value.

Using a Target Product Profile (TPP) during a development programme is well-established best practice to provide focus, enable alignment of both clinical and commercial stakeholders around a common vision, and to facilitate dialogue with regulatory authorities.1 If executed well, a TPP significantly reduces the risk of costly late-stage development failures. < p>

As a statement of intent, a TPP lays out the goals for a product development programme and informs key clinical and commercial decisions along the lifecycle, from early development through to launch.

Naturally, a TPP evolves over time as new information about the product and the relevant market context emerges and refinements to the clinical development programme are made.

For a TPP to be clinically relevant and commercially compelling, it needs to be firmly anchored in an indepth understanding of unmet needs against the backdrop of future competitive dynamics. In addition, a TPP is shaped by healthcare stakeholders’ scrutiny, their definition of value and their expectations for supporting evidence.


Download to read more
Real World Evidence

IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.

Real World Data and Insights

Learn more about the federated evidence networks and massive, non-identified global databases that inform our real world solutions.

Cell & Gene Therapy Center

Access new resources for advanced therapy development, from candidate identification through market authorization.

You may also be interested in
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.